CD4+ T cells were sorted from tumors and tumor-draining lymph nodes of Tslp transgenic (test) or Tslpr knockout (TslprKO, control) mice and stimulated ex vivo using anti-CD3/CD28 antibodies plus TSLP. This evidence concerns the gene CD28 and neoplasm.